ArticleNature biotechnology2010
DNA patents and diagnostics: not a pretty picture.
Article in Nature biotechnology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Are the gene-patent storm clouds dissipating? A global snapshot.Nature biotechnology · 2015Article
- Distributing the future: The weak justifications for keeping human genomic databases secret and the challenges and opportunities in reverse engineering them.Applied & translational genomics · 2014Article
- Commercial landscape of noninvasive prenatal testing in the United States.Prenatal diagnosis · 2013Review
- Commercial Opportunities and Ethical Pitfalls in Personalized Medicine: A Myriad of Reasons to Revisit the Myriad Genetics Saga.Current pharmacogenomics and personalized medicine · 2013Article
- Molecular genetic testing and the future of clinical genomics.Nature reviews. Genetics · 2013Review
- Harm, hype and evidence: ELSI research and policy guidance.Genome medicine · 2013Article
- Biomarker patents for diagnostics: problem or solution?Nature biotechnology · 2012Article
- The fate and future of patents on human genes and genetic diagnostic methods.Nature reviews. Genetics · 2012Review
- Human DNA patent renewals on the decline.Nature biotechnology · 2011Article
- Anchoring gene patent eligibility to its constitutional mooring.Nature biotechnology · 2010Article
- Wrong fixes for gene patents.Nature biotechnology · 2010Article
Corrections and comments
- Commented on by
Authors and funding
7 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.